Pharmabiz14d
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...
Nasdaq16d
HCW Biologics Inc. Receives FDA Clearance for IND Application to Initiate Phase 1 Clinical Trial of HCW9302 for Alopecia Areata
and neurodegenerative diseases where HCW9302 has been shown to have activity in relevant animal models.” , about 7 million people in the United States have alopecia areata. The condition ...
manilatimes16d
HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
MIRAMAR, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. ("HCWB” or the "Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and ...
Pharma company granted FDA clearance for alopecia drug study
The goal is to find a cure for alopecia areata, an autoimmune disease that causes hair loss in distinct round patches.
Nasdaq16d
HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
Alopecia areata causes sudden hair loss and can have ... In multiple relevant preclinical models, HCW9302 has shown efficacy in treating autoimmune diseases at well-tolerated dose levels by ...
New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3
Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., ...
BioSpace16d
HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
and neurodegenerative diseases where HCW9302 has been shown to have activity in relevant animal models.” About Alopecia Areata: Alopecia areata (“AA”) is one of the most prevalent autoimmune diseases ...
BioSpace14d
Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Alopecia Areata
--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA ... The CorEvitas ...
Frontiers16d
Lack of Evidence of COVID-19 Being a Risk Factor of Alopecia Areata: Results of a National Cohort Study in South Korea
Background: Concerns about alopecia areata (AA) in coronavirus disease 2019 (COVID-19 ... of developing AA was estimated using a log-link Poisson regression model based on incidence density. The model ...
Frontiers15d
Mathematical modeling in autoimmune diseases: from theory to clinical application
These 38 models were categorized according to 13 related AD indications, including alopecia areata, atopic dermatitis, autoimmune myocarditis, experimental autoimmune uveitis (EAU), celiac disease, HT ...